Daxor Corporation announced it has entered into an industry partnership with MedAxiom, an American College of Cardiologycompany, to amplify awareness and adoption of Daxor's blood volume analysis (BVA) technology to achieve healthcare's Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.65 USD | -2.92% | -0.92% | +0.52% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.52% | 46.38M | |
+3.00% | 12.52B | |
+7.33% | 8.84B | |
-3.71% | 5.39B | |
+5.13% | 5.16B | |
-0.21% | 5.11B | |
+14.85% | 4.51B | |
+16.63% | 4.44B | |
+1.69% | 4.01B | |
+1.09% | 3.75B |
- Stock Market
- Equities
- DXR Stock
- News Daxor Corporation
- Daxor Corporation Announces Partnership with Medaxiom